Aspirin is considered the cornerstone of secondary prevention of coronary artery disease. However, the evidence supporting aspirin was largely generated before the advent of modern pharmacological and ...
Bristol-Myers Squibb and Sanofi’s Plavix was the top-selling drug in the first quarter of 2012, but it’s time on top may not last long. Bristol-Myers Squibb and Sanofi’s Plavix was the top-selling ...
A commonly prescribed drug could be more effective than aspirin for long-term heart disease prevention. Analysis of nearly 29,000 patients with coronary artery disease (CAD) suggests the blood thinner ...
CHICAGO (Reuters) - A common gene variation explains why many people are not helped by the widely prescribed blood thinner Plavix, U.S. researchers said on Tuesday in a study confirming earlier ...
NEW YORK, Oct 23 (Reuters) - A small study presented on Monday suggests Eli Lilly and Co.'s experimental blood clot preventer, prasugrel, works faster and could be more effective than the commonly ...
Researchers at the European Society of Cardiology Congress reported that the blood thinner clopidogrel should replace aspirin as a routine pill for preventing heart attacks and strokes for people with ...
The Department of Attorney General of Hawaii announced that Bristol-Myers Squibb (NYSE:BMY) and three units of Sanofi (NASDAQ:SNY) have agreed to pay $700M to the state to resolve nearly 12 years of ...
Fitgurú on MSN
Do you drink coffee daily? This hidden interaction with common medications could put your health at risk
Experts warn that your daily caffeine habit may interfere with essential medications in ways you don’t expect.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results